Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.

Dellon EP, Donaldson SH, Johnson R, Davis SD.

Pediatr Pulmonol. 2008 Nov;43(11):1100-1106. doi: 10.1002/ppul.20909.

PMID:
18828160
2.

Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.

Subbarao P, Balkovec S, Solomon M, Ratjen F.

Pediatr Pulmonol. 2007 May;42(5):471-6.

PMID:
17436328
3.

Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.

Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD; ISIS Study Group.

JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.

4.

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group.

N Engl J Med. 2006 Jan 19;354(3):229-40.

5.

Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.

Rosenfeld M, Davis S, Brumback L, Daniel S, Rowbotham R, Johnson R, McNamara S, Jensen R, Barlow C, Ratjen F.

Pediatr Pulmonol. 2011 Jul;46(7):666-71. doi: 10.1002/ppul.21425. Epub 2011 Mar 1.

6.

Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.

Brivio A, Conese M, Gambazza S, Biffi A, Tirelli AS, Russo M, Foà M, Colombo C.

J Aerosol Med Pulm Drug Deliv. 2016 Dec;29(6):482-489. Epub 2016 May 5.

PMID:
27149365
7.

[Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis].

Máiz Carro L, Lamas Ferreiro A, Ruiz de Valbuena Maiz M, Wagner Struwing C, Gabilondo Álvarez G, Suárez Cortina L.

Med Clin (Barc). 2012 Feb 4;138(2):57-9. doi: 10.1016/j.medcli.2011.02.022. Epub 2011 Apr 20. Spanish.

PMID:
21511313
8.

Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.

Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.

J Aerosol Med Pulm Drug Deliv. 2014 Apr;27(2):133-7. doi: 10.1089/jamp.2012.1034. Epub 2013 Jun 8.

PMID:
23745525
9.

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF.

Pediatr Pulmonol. 1996 Feb;21(2):77-83.

PMID:
8882210
10.

Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.

Corcoran TE, Godovchik JE, Donn KH, Busick DR, Goralski J, Locke LW, Markovetz MR, Myerburg MM, Muthukrishnan A, Weber L, Lacy RT, Pilewski JM.

Pediatr Pulmonol. 2017 Sep;52(9):1142-1149. doi: 10.1002/ppul.23749. Epub 2017 Jul 24.

PMID:
28737262
11.

Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.

O'Connell OJ, O'Farrell C, Harrison MJ, Eustace JA, Henry MT, Plant BJ.

Respir Care. 2011 Jun;56(6):771-5. doi: 10.4187/respcare.00866. Epub 2011 Feb 11.

12.

Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.

Laube BL, Sharpless G, Carson KA, Kelly A, Mogayzel PJ Jr.

BMC Pulm Med. 2011 Sep 6;11:45. doi: 10.1186/1471-2466-11-45.

13.

Hypertonic saline and PEP: is it worth a try?

O'Malley CA.

Respir Care. 2011 Jun;56(6):886-7. doi: 10.4187/respcare.01358. No abstract available.

14.

[Effectiveness of inhaled hypertonic saline in children with bronchiolitis].

Li G, Zhao J.

Zhonghua Er Ke Za Zhi. 2014 Aug;52(8):607-10. Chinese.

PMID:
25224239
15.

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.

Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT.

Thorax. 1997 Oct;52(10):900-3.

16.

Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.

Hordvik NL, Sammut PH, Judy CG, Colombo JL.

Pediatr Pulmonol. 2002 Oct;34(4):287-96.

PMID:
12205570
17.

Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.

Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK.

J Trop Pediatr. 2012 Oct;58(5):375-81. doi: 10.1093/tropej/fms004. Epub 2012 Feb 28.

PMID:
22374985
18.

A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants.

Flores P, Mendes AL, Neto AS.

Pediatr Pulmonol. 2016 Apr;51(4):418-25. doi: 10.1002/ppul.23306. Epub 2015 Sep 3.

PMID:
26334188
19.

Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis.

Ho SA, Ball R, Morrison LJ, Brownlee KG, Conway SP.

Pediatr Pulmonol. 2004 Jul;38(1):82-7.

PMID:
15170878
20.

Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):456-60. doi: 10.1164/rccm.201302-0219OC.

Supplemental Content

Support Center